Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized, placebo-controlled, 26-week trial in patients with type 2 diabetes
- Resource Type
- Article
- Source
- In
Journal of Diabetes and Its Complications March-April 2013 27(2):177-183 - Subject
- Language
- ISSN
- 1056-8727